Wholesale of pharmaceutical and medical goods
RAYONEX BIOMEDICAL NORWAY AS
Revenue 2025
NOK 702,000
Operating profit
NOK 95,000
Equity
NOK 285,000
Incorporated
2016
Share capital
NOK 30,000
Key figures · 2025
Current ratio
2.25
Equity ratio
81.6%
Key figures over time · 2025
| Key figures | 2025 | Trend |
|---|---|---|
| Lønnsomhet | ||
| Operating margin (%%) | 13.5% | |
| Net margin (%%) | 14.2% | |
| Return on assets (%%) | 27.1% | |
| Likviditet | ||
| Current ratio | 2.25 | |
| Working capital | 76k | |
| Soliditet | ||
| Equity ratio (%%) | 81.6% | |
| Debt-to-equity ratio | 0.23 | |
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.